Manufactured in South Korea as a professional Use fat Dissolving injectable; regulatory status and classification may vary by country.
Distributed through licensed aesthetic pharmacies and wholesalers; should be used only by qualified practitioners in line with local regulations and scope of practice.
Manufactured in South Korea as a professional Use fat Dissolving injectable; regulatory status and classification may vary by country.
Distributed through licensed aesthetic pharmacies and wholesalers; should be used only by qualified practitioners in line with local regulations and scope of practice.
Facial Fat-Dissolving Injection
Description
Lipo Lab V-Line is a premium facial fat-dissolving solution formulated specifically for V-line contouring. It combines phosphatidylcholine and sodium deoxycholate with vitamins, amino acids, plant extracts and biomimetic peptides to reduce localised fat in the chin, jawline and cheeks while improving skin elasticity, tone and hydration. The product is manufactured in South Korea using high-purity raw materials from Japan and Germany and is designed for professional subcutaneous injection to slim the lower face and lift sagging contours.
Bnefits
Targets localised fat deposits in the chin, jawline, cheeks and neckline to create a more defined V-shaped facial contour.
Combines powerful lipolytic agents with vitamins, amino acids and plant extracts to dissolve and eliminate fat cells rather than just shrinking them.
Improves skin elasticity, firmness and tone, helping to prevent post-treatment sagging.
Biomimetic peptide complex provides strong skin-tightening and lifting effects while supporting collagen and elastin production.
Promotes lymphatic circulation, helping to reduce swelling and remove dissolved fat through natural metabolic pathways.
Quick treatment time (typically 5–20 minutes per session) with little to no downtime.
Results usually begin to appear within 2–3 weeks, with effects that can last 9 months or longer after a full treatment course.
Ready-to-use solution that does not require mixing and features a small particle size for efficient penetration into the fat layer.
Indications
Reduction of localised facial fat in the lower face and submental (double chin) area.
Slimming and definition of the V-line and jawline.
Reduction of fullness in the cheeks ("hamster cheeks").
Improvement of sagging skin and excessive adipose tissue on the face and selected small body areas.
Regeneration and tightening of skin with reduced elasticity in the treated zones.
Adjunctive treatment for patients seeking non-surgical facial contouring and slimming.
Biomimetic peptide complex including acetyl-hexapeptide-8, palmitoyl pentapeptide-4 and palmitoyl tetrapeptide-7 – peptides that smooth wrinkles, stimulate collagen and enhance skin thickness and firmness.
Formulation
Sterile injectable lipolytic solution for subcutaneous use in the face and selected small body areas.
High-purity active ingredients sourced from Japan and Germany incorporated into a South Korean-manufactured formula.
Combination of PPC and sodium deoxycholate with vitamins, amino acids, plant extracts, peptides and hyaluronate for simultaneous fat reduction and skin rejuvenation.
Small particle size designed to penetrate deep into the subcutaneous fat layer for effective lipolysis.
Ready-to-use solution that does not require reconstitution or mixing prior to injection.
Designed specifically for delicate facial tissues and V-line contouring rather than large body areas.
Packaging
Typical clinic presentation: 5 vials × 10 ml per box for facial protocols.
Some manufacturers and wholesalers also offer 10 vials × 10 ml per box formats.
Individual sterile 10 ml glass vials with rubber stoppers and sealed caps for single-patient treatment sessions.
Outer carton printed with product name, batch number, expiry date and manufacturer or importer information.
Labelled for professional use only; purchaser usually must declare appropriate medical or aesthetic qualifications.
Usage
For subcutaneous injection only and must be administered by suitably trained and licensed medical or aesthetic professionals.
Shake the vial well before use, ensuring visible particles are evenly dispersed; check integrity of vial, seal and expiry date before opening.
Cleanse and disinfect the treatment area thoroughly to minimise risk of infection.
Recommended injection depth for facial areas is approximately 5 mm into the subcutaneous fat layer, avoiding intradermal or intramuscular injection.
Inject approximately 0.1–0.2 ml per point with injection points spaced around 1 cm apart to ensure even distribution.
Do not exceed a total of about 2 ml per full-face session, adjusting dose to patient anatomy and clinical judgement.
Typical course involves at least 3 sessions, often 3–5, spaced about 10 days apart; some protocols may vary the interval slightly based on response.
After injection, avoid massaging or excessively manipulating the treated area unless specifically indicated by protocol.
Advise patients to avoid alcohol, strenuous exercise, saunas, hot baths and direct heat exposure for 24–48 hours post-treatment.
Instruct patients to maintain good hydration to support lymphatic drainage and elimination of dissolved fat.
Monitor for unexpected pain, blanching, severe swelling or other adverse reactions during and after treatment and manage according to clinical guidelines.
Do not mix Lipo Lab V-Line in the same syringe with other injectable products unless explicitly authorised by the manufacturer.
Contraindications
Known hypersensitivity or allergy to phosphatidylcholine, sodium deoxycholate, plant extracts, L-carnitine, peptides, vitamins or any other component of the formulation.
Documented allergy to soy or soy-derived products (PPC is often soy-derived).
Pregnancy or breastfeeding.
Active skin infections, inflammatory conditions, open wounds or severe irritation in the intended treatment area.
Severe or uncontrolled systemic illness (such as significant cardiac, hepatic, renal or metabolic disease) without prior medical clearance.
History of severe allergic reactions or anaphylaxis to injectable treatments.
Bleeding disorders or current use of potent anticoagulant or antiplatelet medications without appropriate risk–benefit assessment.
Autoimmune or immunosuppressive conditions unless carefully evaluated by a physician.
Use in patients under 18 years of age unless permitted by local regulation and under specialist supervision.
Any other contraindications or cautions specified by the manufacturer or local clinical guidelines.
Adverse Effects
Common transient reactions including local redness, swelling, warmth, tenderness and bruising at injection sites.
Temporary pain, burning or stinging sensation during and shortly after injection.
Mild itching, tingling or sensitivity in the treated area.
Localised firmness, nodules or lumpiness as fat breaks down and tissues remodel.
Short-term swelling or puffiness in the lower face or neck that usually subsides within a few days.
Occasional asymmetry or uneven contouring that may require further management or additional sessions to correct.
Rare but more serious complications such as infection, marked inflammatory response, allergic or hypersensitivity reactions, nerve irritation or, very rarely, tissue damage requiring prompt medical attention.
Storage Conditions
Store at controlled room temperature as indicated on the packaging, typically in a cool, dry place away from direct sunlight.
Do not freeze the product.
Keep vials in their original carton until use to protect from light and contamination.
Use only before the expiry date printed on the vial and outer packaging.
Discard any vial that shows signs of damage, compromised seal, leakage or abnormal solution appearance (such as unexpected discoloration or large particulate matter).
Keep out of reach of children.
Follow any additional storage instructions provided by the manufacturer or distributor.
Duration
A typical treatment course consists of 3\u20135 sessions spaced approximately 10 days apart, with clinical effects usually lasting 9 months or longer when the full protocol is completed and the patient maintains a stable weight and healthy lifestyle.
Onset
Noticeable improvements in contour and skin quality are commonly reported within 2\u20133 weeks after the first session, with full results developing over several weeks as additional sessions are completed and the body clears dissolved fat.
